Page last updated: 2024-08-24

halofuginone and Liver Cirrhosis

halofuginone has been researched along with Liver Cirrhosis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's5 (62.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, MH; Li, Y; Li, YY; Liang, J; Liu, JB; Shen, RW; Zhang, B; Zhang, W1
Gao, MH; Geng, X; Li, Y; Li, YY; Liang, J; Liu, JB; Shen, RW; Zhang, B; Zhang, W1
Alexiev, R; Anbinder, N; Genina, O; Mawasi, N; Paizi, M; Pines, M; Spira, G1
Bauer, M; Niedobitek, E; Patsenker, E; Popov, Y; Schulze-Krebs, A; Schuppan, D1
Bruck, R; Genina, O; Gnainsky, Y; Halevy, O; Nagler, A; Paizi, M; Pines, M; Spira, G; Taub, R1
Bilu, G; Bruck, R; Genina, O; Gnainsky, Y; Hagai, Y; Kawada, N; Kushnirsky, Z; Libermann, TA; Nagler, A; Pines, M; Reinhardt, DP; Spira, G; Volpin, H; Yoshizato, K1
Nagler, A; Pines, M1
Aeed, H; Alexiev, R; Avni, Y; Bruck, R; Genina, O; Nagler, A; Pines, M1

Reviews

1 review(s) available for halofuginone and Liver Cirrhosis

ArticleYear
Halofuginone: a novel antifibrotic therapy.
    General pharmacology, 1998, Volume: 30, Issue:4

    Topics: Animals; Collagen; Fibrosis; Humans; Liver Cirrhosis; Piperidines; Postoperative Complications; Protein Synthesis Inhibitors; Pulmonary Fibrosis; Quinazolines; Quinazolinones; Skin; Tissue Adhesions

1998

Other Studies

7 other study(ies) available for halofuginone and Liver Cirrhosis

ArticleYear
Preventive effect of halofuginone on concanavalin A-induced liver fibrosis.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Concanavalin A; Drugs, Chinese Herbal; Interleukin-1beta; Interleukin-6; Liver Cirrhosis; Male; Piperidines; Quinazolinones; Rats, Wistar; Transforming Growth Factor beta1

2013
The effect of antifibrotic drug halofugine on Th17 cells in concanavalin A-induced liver fibrosis.
    Scandinavian journal of immunology, 2014, Volume: 79, Issue:3

    Topics: Actins; Alanine Transaminase; Albumins; Animals; Aspartate Aminotransferases; Cell Differentiation; Concanavalin A; Disease Models, Animal; Interferon-gamma; Interleukin-10; Interleukin-17; Interleukin-1beta; Interleukin-33; Interleukin-6; Interleukins; Liver; Liver Cirrhosis; Male; Nuclear Receptor Subfamily 1, Group F, Member 3; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; Rats; Rats, Wistar; Th17 Cells; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha

2014
Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic rats.
    Journal of hepatology, 2002, Volume: 37, Issue:3

    Topics: Animals; Collagen Type I; Extracellular Matrix; Liver Cirrhosis; Liver Regeneration; Male; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Rats; Rats, Sprague-Dawley; Thioacetamide

2002
Halofuginone induces matrix metalloproteinases in rat hepatic stellate cells via activation of p38 and NFkappaB.
    The Journal of biological chemistry, 2006, Jun-02, Volume: 281, Issue:22

    Topics: Animals; Cell Line; Cell Movement; Cell Proliferation; Cells, Cultured; Collagenases; Enzyme Induction; Hepatocytes; Liver Cirrhosis; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 13; Matrix Metalloproteinase 3; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Piperidines; Quinazolines; Quinazolinones; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction

2006
Involvement of the tyrosine phosphatase early gene of liver regeneration (PRL-1) in cell cycle and in liver regeneration and fibrosis effect of halofuginone.
    Cell and tissue research, 2006, Volume: 324, Issue:3

    Topics: Animals; Cell Cycle; Cell Proliferation; Cells, Cultured; Early Growth Response Protein 1; Hepatocytes; Immediate-Early Proteins; Insulin-Like Growth Factor Binding Protein 1; Liver Cirrhosis; Liver Regeneration; Male; Piperidines; Protein Tyrosine Phosphatases; Quinazolinones; Rats; Rats, Wistar

2006
Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling.
    Cell and tissue research, 2007, Volume: 328, Issue:1

    Topics: Acid Phosphatase; Animals; Antineoplastic Agents; Cluster Analysis; Cytoglobin; Disease Progression; Fibrillin-1; Fibrillins; Gene Expression Profiling; Gene Expression Regulation; Globins; Hepatocytes; Humans; Isoenzymes; Liver Cirrhosis; Male; Microfilament Proteins; Nuclear Proteins; Osteopontin; Phosphorylation; Piperidines; Quinazolinones; Rats; Rats, Wistar; Signal Transduction; Smad2 Protein; Smad3 Protein; Substrate Specificity; Tartrate-Resistant Acid Phosphatase; Thioacetamide; Transforming Growth Factor beta

2007
Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats.
    Hepatology (Baltimore, Md.), 2001, Volume: 33, Issue:2

    Topics: Animals; Cell Division; Liver; Liver Cirrhosis; Male; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Rats; Rats, Wistar; Thioacetamide

2001